Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(93 sites)
United States
Center for Dermatology and Plastic Surgery- Site Number : 8400111, Scottsdale, Arizona Private Practice - Dr. Francisco Badar- Site Number : 8400067, Cerritos, California Encino Research Center- Site Number : 8400033, Encino, California Paradigm Clinical Research Centers- Site Number : 8400064, La Mesa, California Sunwise Clinical Research- Site Number : 8400108, Lafayette, California